Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-12-22FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Byetta (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS research · 2006-12-22Clinical Trial Update: Evaluation of Effect of Exercise on Prescription [Phase 2, Phase 3]
An ongoing Phase 2/Phase 3 clinical trial evaluating the effect of exercise on prescription for adults with metabolic syndrome and type 2 di…
-
CLINICAL_TRIALS research · 2006-12-21Clinical Trial Update: Metformin for the Treatment of Diabetes in Pregnancy [Phase 3]
A Phase 3 clinical trial update on using metformin to treat diabetes in pregnancy, including gestational diabetes mellitus and diabetes mell…
-
CLINICAL_TRIALS research · 2006-12-19Clinical Trial Update: Study of Renal Blood Flow During Human Endotoxemia [NA]
Clinical trial update on renal blood flow during human endotoxemia involving healthy individuals and those with type 2 diabetes; the current…
-
CLINICAL_TRIALS research · 2006-12-19Clinical Trial Update: Type 2 Diabetes and the Effect of Probiotics [NA]
A clinical trial update on the effect of probiotics in individuals with type 2 diabetes and endotoxemia, with the study status currently unk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-12-15Clinical Trial Update: Effect of Mobile Communication With a Cellular Phone With a Glucometer on Glucose Control in Type 2 Diabetic Patients [NA]
The trial evaluating mobile communication with a glucometer to improve glucose control in type 2 diabetes mellitus was terminated.
-
CLINICAL_TRIALS research · 2006-12-14Clinical Trial Update: The Gene Expression Patterns in the Peripheral White Blood Cells of Type 2 Diabetic Patients
A clinical trial update examining gene expression patterns in peripheral white blood cells of patients with type 2 diabetes mellitus, with c…
-
EMA withdrawal · 2006-12-08EMA Application withdrawn: Synordia (fenofibrate;metformin) — Fournier Laboratories Ireland Ltd.
The EMA withdrew the application for Synordia (fenofibrate; metformin) from Fournier Laboratories Ireland Ltd. for Diabetes Type 2.
-
CLINICAL_TRIALS trial_result · 2006-11-16Clinical Trial Update: Dietary Fish Protein in Subjects With Insulin Resistance [Phase 2]
A Phase 2 clinical trial evaluating dietary fish protein in people with insulin resistance and type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2006-11-08Clinical Trial Update: Double Blind Randomized Trial to Compare Gurmar (Gymnema Sylvestre) With Metformin in Type 2 Diabetes [NA]
A double-blind randomized trial is comparing Gurmar (Gymnema sylvestre) with Metformin for Type 2 Diabetes; the current status of the trial …
-
FDA approval · 2006-11-04FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) from Takeda Pharmaceuticals America,…
-
CLINICAL_TRIALS trial_result · 2006-11-02Clinical Trial Update: The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 Diabetes [NA]
A completed clinical trial evaluating the Diabetes Specialist Nurse as the delegated main care provider for patients with Type 2 diabetes. T…
-
FDA approval · 2006-11-01FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP. The action updates or expands th…
-
FDA approval · 2006-11-01FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA has approved a supplemental application for Metformin Hydrochloride from Oceanside Pharmaceuticals. The approval adds or changes to …
-
CLINICAL_TRIALS trial_result · 2006-10-31Clinical Trial Update: MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics) [Phase 2]
Phase 2 clinical trial MATCHED evaluating MC-1 in combination with ACE Therapeutic for type 2 diabetes mellitus and hypertension (metabolic …
-
FDA approval · 2006-10-27FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk.
-
CLINICAL_TRIALS research · 2006-10-18Clinical Trial Update: Multiple Grain in Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update on a multiple-grain intervention for type 2 diabetes, sponsored by National Cheng-Kung University Hospital.
-
FDA approval · 2006-10-16FDA Approved: JANUVIA — Original Application (Merck Sharp & Dohme LLC)
FDA approves JANUVIA (sitagliptin) under the original application from Merck Sharp & Dohme LLC for the treatment of type 2 diabetes mellitus…
-
FDA approval · 2006-10-12FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP. This action updates the appr…
-
CLINICAL_TRIALS trial_result · 2006-10-09Clinical Trial Update: Olmesartan Medoxomil and Diabetic Nephropathy [Phase 3]
A Phase 3 trial evaluating Olmesartan Medoxomil for diabetic nephropathy in type 2 diabetes has been completed.
-
FDA approval · 2006-09-28FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Actoplus Met, a fixed-dose combination of pioglitazone and metformin hydrochloride. The product …
-
FDA approval · 2006-09-28FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approves a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2006-09-28Clinical Trial Update: Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin [Phase 3]
A Phase 3 trial evaluating miglitol’s effect on daily plasma glucose in insulin-treated type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-27Clinical Trial Update: Double-Blind Study of Miglitol in Japanese With type2 Diabetes [Phase 3]
Phase 3 double-blind trial evaluating miglitol in Japanese patients with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-21Clinical Trial Update: Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment [Phase 3]
Phase 3 double-blind trial evaluating miglitol in adults with Type 2 diabetes treated with insulin; the study has been completed.